S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
MarketBeat Week in Review – 4/15 - 4/19
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion

Eagle Pharmaceuticals (EGRX) News Today

$4.61
+0.13 (+2.90%)
(As of 04/19/2024 ET)
SourceHeadline
MarketBeat logoEagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Crosses Below Two Hundred Day Moving Average of $7.47
americanbankingnews.com - April 17 at 3:46 AM
globenewswire.com logoEagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
globenewswire.com - April 15 at 7:00 AM
investing.com logoEagle Pharmaceuticals faces potential Nasdaq delisting
investing.com - April 14 at 12:24 AM
msn.com logoStocks Slightly Higher as US Mar PPI Climbs Less Than Expected
msn.com - April 13 at 9:24 AM
msn.com logoStocks Mixed as Bond Yields Climb
msn.com - April 13 at 9:24 AM
finance.yahoo.com logoEagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
finance.yahoo.com - April 12 at 7:25 PM
globenewswire.com logoEagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
globenewswire.com - April 12 at 4:05 PM
msn.com logoEagle Pharmaceuticals to cut 36% of workforce
msn.com - February 29 at 12:59 PM
benzinga.com logoEagle Pharmaceuticals Stock (NASDAQ:EGRX), Short Interest Report
benzinga.com - February 22 at 7:58 PM
benzinga.com logoEagle Pharmaceuticals Stock (NASDAQ:EGRX) Dividends: History, Yield and Dates
benzinga.com - February 22 at 7:58 PM
marketbeat.com logoBrandes Investment Partners LP Boosts Stock Holdings in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
marketbeat.com - February 19 at 1:27 PM
prnewswire.com logoEAGLE PHARMACEUTICALS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
prnewswire.com - February 9 at 12:00 PM
stockhouse.com logoThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
stockhouse.com - February 8 at 8:33 PM
markets.businessinsider.com logoLevi & Korsinsky Notifies Shareholders of Eagle Pharmaceuticals, Inc.(EGRX) of a Class Action Lawsuit and an Upcoming Deadline
markets.businessinsider.com - February 8 at 8:33 PM
markets.businessinsider.com logoShareholders that lost money on Eagle Pharmaceuticals, Inc.(EGRX) should contact Levi & Korsinsky about pending Class Action - EGRX
markets.businessinsider.com - February 8 at 2:15 PM
markets.businessinsider.com logoClass Action Filed Against Eagle Pharmaceuticals, Inc. (EGRX) Seeking Recovery for Investors - Contact Levi & Korsinsky
markets.businessinsider.com - February 7 at 3:47 PM
stockhouse.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline
stockhouse.com - February 6 at 10:37 AM
stockhouse.com logo7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - February 2 at 3:06 PM
barrons.com logoEGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm!
barrons.com - February 2 at 10:06 AM
marketbeat.com logoAssenagon Asset Management S.A. Has $3.43 Million Stock Position in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
marketbeat.com - February 2 at 5:40 AM
stockhouse.com logoINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - February 1 at 2:00 PM
marketbeat.com logoEagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Passes Below Two Hundred Day Moving Average of $12.10
marketbeat.com - February 1 at 3:55 AM
markets.businessinsider.com logoEGRX 9-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals (EGRX) Investors with Substantial Losses to Contact Firm Before Feb. 9th Deadline in Securities...
markets.businessinsider.com - February 1 at 1:08 AM
stockhouse.com logoINVESTOR ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EGRX
stockhouse.com - January 31 at 1:45 PM
barrons.com logoINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
barrons.com - January 31 at 1:45 PM
stockhouse.com logoINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - January 30 at 3:28 PM
stockhouse.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. (EGRX) Investors of a Class Action Lawsuit and Upcoming Deadline
stockhouse.com - January 30 at 10:28 AM
stockhouse.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceuticals, Inc. - EGRX
stockhouse.com - January 28 at 10:13 PM
markets.businessinsider.com logoEagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on Lender Agreement - Hagens Berman
markets.businessinsider.com - January 28 at 12:12 PM
investing.com logoEagle Pharmaceuticals Inc (EGRX)
investing.com - January 23 at 8:02 AM
markets.businessinsider.com logoSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
markets.businessinsider.com - January 19 at 6:03 PM
finanznachrichten.de logoEagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
finanznachrichten.de - January 18 at 1:11 PM
finance.yahoo.com logoEagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
finance.yahoo.com - January 18 at 8:11 AM
markets.businessinsider.com logoEagle Pharmaceuticals Deadline Reminder
markets.businessinsider.com - January 14 at 12:37 PM
stockhouse.com logoSHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EGRX
stockhouse.com - January 11 at 2:45 PM
msn.com logoSHAREHOLDER ALERT: Potential Recovery for Eagle Pharmaceuticals, Inc. (EGRX) Investors
msn.com - January 3 at 8:13 PM
businesswire.com logoROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
businesswire.com - January 2 at 6:27 PM
markets.businessinsider.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. - EGRX
markets.businessinsider.com - December 31 at 12:14 PM
markets.businessinsider.com logoEagle Pharmaceuticals Shareholder Action Reminder
markets.businessinsider.com - December 22 at 1:28 PM
stockhouse.com logoFINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses to Contact the Firm
stockhouse.com - December 22 at 8:27 AM
stockhouse.com logoDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
stockhouse.com - December 17 at 10:58 PM
markets.businessinsider.com logoEagle Pharmaceuticals Ongoing Deadline Alert
markets.businessinsider.com - December 17 at 12:58 PM
barrons.com logoSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eagle Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
barrons.com - December 14 at 9:57 PM
businesswire.com logoDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
businesswire.com - December 14 at 11:17 AM
tmcnet.com logoGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
tmcnet.com - December 13 at 10:16 PM
tmcnet.com logoKirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
tmcnet.com - December 13 at 5:16 PM
tmcnet.com logoEagle Pharmaceuticals, Inc. (EGRX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Eagle Pharmaceuticals, Inc.
tmcnet.com - December 13 at 5:16 PM
financialpost.com logoEAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
financialpost.com - December 12 at 10:06 PM
tmcnet.com logoThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
tmcnet.com - December 12 at 4:13 PM
markets.businessinsider.com logoEagle Pharmaceuticals (EGRX) Engaged in Accounting Fraud, Investor Suit Alleges - Hagens Berman
markets.businessinsider.com - December 12 at 4:13 PM
Get Eagle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

EGRX Media Mentions By Week

EGRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EGRX
News Sentiment

0.12

0.51

Average
Medical
News Sentiment

EGRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EGRX Articles
This Week

5

2

EGRX Articles
Average Week

Get Eagle Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:EGRX) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners